Genetic Characteristics of Histone H 3 K 27 M-mutant Diffuse Midline Gliomas in Adults

© The Author(s) 2020. Published by Oxford University Press, the Society for NeuroOncology and the European Association of Neuro-Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Clinical, Radiologic, and Genetic Characteristics of Histone H3 K27M-mutant Diffuse Midline Gliomas in Adults

[1]  S. El-Naggar,et al.  Histone H3K27M Mutation Overrides Histological Grading in Pediatric Gliomas , 2020, Scientific Reports.

[2]  Jinsong Wu,et al.  Imaging characteristics of adult H3 K27M-mutant gliomas. , 2019, Journal of neurosurgery.

[3]  Kaanan P. Shah,et al.  Integrated genomic profiling expands clinical options for patients with cancer , 2019, Nature Biotechnology.

[4]  Warren A. Cheung,et al.  H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis , 2019, Nature Communications.

[5]  C. Bettegowda,et al.  Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas , 2019, Journal of Neuro-Oncology.

[6]  Barbara S. Paugh,et al.  Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression. , 2019, Cancer cell.

[7]  Huiying Liang,et al.  H3 K27M-mutant diffuse midline gliomas in different anatomical locations. , 2018, Human pathology.

[8]  B. Kleinschmidt-DeMasters,et al.  H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis , 2018, Clinical neuropathology.

[9]  A. Riccio,et al.  H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas. , 2017, Cancer cell.

[10]  Kun Mu,et al.  Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma , 2017, Cancer cell.

[11]  Sunit Das,et al.  The Role of ATRX in Glioma Biology , 2017, Front. Oncol..

[12]  F. Ducray,et al.  Characteristics of H3 K27M-mutant gliomas in adults , 2017, Neuro-oncology.

[13]  M. Berger,et al.  Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma , 2017, Acta Neuropathologica Communications.

[14]  B. Hoeben,et al.  Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group. , 2017, European journal of cancer.

[15]  M. Aboian,et al.  Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation , 2017, American Journal of Neuroradiology.

[16]  David T. W. Jones,et al.  Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease , 2017, Journal of Neuro-Oncology.

[17]  Benjamin M. Ellingson,et al.  Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials , 2017, Neurotherapeutics.

[18]  Arie Perry,et al.  Diffuse Midline Gliomas with Histone H3‐K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations , 2016, Brain pathology.

[19]  Z. Ram,et al.  Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients , 2016, Journal of Neuro-Oncology.

[20]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[21]  A. Ghazalpour,et al.  Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies , 2016, Oncotarget.

[22]  Hai Yan,et al.  The H3.3 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults. , 2015, Human pathology.

[23]  David T. W. Jones,et al.  Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers , 2015, Acta Neuropathologica.

[24]  C. Hawkins,et al.  Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications , 2014, Acta Neuropathologica.

[25]  Amar Gajjar,et al.  The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma , 2014, Nature Genetics.

[26]  Liliana Goumnerova,et al.  Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma , 2014, Nature Genetics.

[27]  Kuniaki Saito,et al.  H3F3A K27M mutations in thalamic gliomas from young adult patients. , 2014, Neuro-oncology.

[28]  D. Haussler,et al.  The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.

[29]  Ashish Choudhary,et al.  Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens. , 2013, The Journal of molecular diagnostics : JMD.

[30]  C. Kramm,et al.  H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas. , 2013, American journal of clinical pathology.

[31]  David T. W. Jones,et al.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.

[32]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[33]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[34]  A. Gajjar,et al.  Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. , 2004, The oncologist.